The Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisation for Mounjaro, a new therapy, to manage type 2 diabetes in adults. This decision comes after encouraging results from clinical trials that showed Mounjaro significantly lowers blood sugar levels in patients. Mounjaro is a a once-weekly injection that acts